PharmaCyte Biotech, Inc. (PMCB) News https://ir.pharmacyte.com/annual-reports/rss PharmaCyte Biotech, Inc. (PMCB) - Annual Reports en-us Equisolve Investor Relations Suite http://content.stockpr.com/pharmacytebiotech/files/PharmaCyteBiotech-logo.png https://www.pharmacyte.com <![CDATA[ 10-K - Annual report [Section 13 and 15(d), not S-K Item 405] ]]> 10-K, EX-3.6, EX-21.1, EX-23.1, EX-31.1, EX-31.2, EX-32.1, EX-32.2 ]]> https://ir.pharmacyte.com/annual-reports?page=1#document-2879-0001683168-26-005836 Wed, 29 Jul 26 16:59:33 -0400 https://ir.pharmacyte.com/annual-reports?page=1#document-2879-0001683168-26-005836 <![CDATA[ 4/A - Statement of changes in beneficial ownership of securities ]]> https://ir.pharmacyte.com/annual-reports?page=1#document-2871-0001683168-26-005619 Fri, 17 Jul 26 17:00:53 -0400 https://ir.pharmacyte.com/annual-reports?page=1#document-2871-0001683168-26-005619 <![CDATA[ 4/A - Statement of changes in beneficial ownership of securities ]]> https://ir.pharmacyte.com/annual-reports?page=1#document-2870-0001683168-26-005620 Fri, 17 Jul 26 17:00:48 -0400 https://ir.pharmacyte.com/annual-reports?page=1#document-2870-0001683168-26-005620 <![CDATA[ 4/A - Statement of changes in beneficial ownership of securities ]]> https://ir.pharmacyte.com/annual-reports?page=1#document-2869-0001683168-26-005621 Fri, 17 Jul 26 17:00:43 -0400 https://ir.pharmacyte.com/annual-reports?page=1#document-2869-0001683168-26-005621 <![CDATA[ 4/A - Statement of changes in beneficial ownership of securities ]]> https://ir.pharmacyte.com/annual-reports?page=1#document-2868-0001683168-26-005622 Fri, 17 Jul 26 17:00:38 -0400 https://ir.pharmacyte.com/annual-reports?page=1#document-2868-0001683168-26-005622 <![CDATA[ 4 - Statement of changes in beneficial ownership of securities ]]> https://ir.pharmacyte.com/annual-reports?page=1#document-2860-0001683168-26-002632 Thu, 02 Apr 26 18:17:51 -0400 https://ir.pharmacyte.com/annual-reports?page=1#document-2860-0001683168-26-002632 <![CDATA[ 8-K - Current report ]]> 8-K, EX-10.1 ]]> https://ir.pharmacyte.com/annual-reports?page=1#document-2856-0001683168-26-002613 Thu, 02 Apr 26 16:20:22 -0400 https://ir.pharmacyte.com/annual-reports?page=1#document-2856-0001683168-26-002613 <![CDATA[ 4 - Statement of changes in beneficial ownership of securities ]]> 4, EX-24.1 ]]> https://ir.pharmacyte.com/annual-reports?page=1#document-2858-0001683168-26-002630 Thu, 02 Apr 26 18:17:15 -0400 https://ir.pharmacyte.com/annual-reports?page=1#document-2858-0001683168-26-002630 <![CDATA[ 4 - Statement of changes in beneficial ownership of securities ]]> https://ir.pharmacyte.com/annual-reports?page=1#document-2859-0001683168-26-002631 Thu, 02 Apr 26 18:17:30 -0400 https://ir.pharmacyte.com/annual-reports?page=1#document-2859-0001683168-26-002631 <![CDATA[ 4 - Statement of changes in beneficial ownership of securities ]]> https://ir.pharmacyte.com/annual-reports?page=1#document-2861-0001683168-26-002633 Thu, 02 Apr 26 18:17:56 -0400 https://ir.pharmacyte.com/annual-reports?page=1#document-2861-0001683168-26-002633 <![CDATA[ SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors ]]> https://ir.pharmacyte.com/annual-reports?page=2#document-2863-0001683168-26-001988 Tue, 14 Apr 26 12:28:56 -0400 https://ir.pharmacyte.com/annual-reports?page=2#document-2863-0001683168-26-001988 <![CDATA[ 4 - Statement of changes in beneficial ownership of securities ]]> https://ir.pharmacyte.com/annual-reports?page=2#document-2854-0001683168-26-001989 Wed, 18 Mar 26 17:08:28 -0400 https://ir.pharmacyte.com/annual-reports?page=2#document-2854-0001683168-26-001989 <![CDATA[ 10-Q - Quarterly report [Sections 13 or 15(d)] ]]> 10-Q, EX-31.1, EX-31.2, EX-32.1, EX-32.2 ]]> https://ir.pharmacyte.com/annual-reports?page=2#document-2852-0001683168-26-001917 Tue, 17 Mar 26 15:50:35 -0400 https://ir.pharmacyte.com/annual-reports?page=2#document-2852-0001683168-26-001917 <![CDATA[ DEF 14A - Definitive proxy statements ]]> https://ir.pharmacyte.com/annual-reports?page=2#document-2846-0001683168-26-001593 Mon, 09 Mar 26 06:03:56 -0400 https://ir.pharmacyte.com/annual-reports?page=2#document-2846-0001683168-26-001593 <![CDATA[ ARS - Annual Report to Security Holders ]]> https://ir.pharmacyte.com/annual-reports?page=2#document-2847-0001683168-26-001600 Mon, 09 Mar 26 09:40:34 -0400 https://ir.pharmacyte.com/annual-reports?page=2#document-2847-0001683168-26-001600 <![CDATA[ PRE 14A - Preliminary proxy statement not related to a contested matter or merger/acquisition ]]> https://ir.pharmacyte.com/annual-reports?page=2#document-2845-0001683168-26-001363 Fri, 27 Feb 26 17:06:22 -0500 https://ir.pharmacyte.com/annual-reports?page=2#document-2845-0001683168-26-001363 <![CDATA[ SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors ]]> https://ir.pharmacyte.com/annual-reports?page=2#document-2867-0001213900-26-016526 Tue, 14 Apr 26 12:29:04 -0400 https://ir.pharmacyte.com/annual-reports?page=2#document-2867-0001213900-26-016526 <![CDATA[ 4 - Statement of changes in beneficial ownership of securities ]]> https://ir.pharmacyte.com/annual-reports?page=2#document-2838-0001683168-26-000147 Wed, 07 Jan 26 17:43:40 -0500 https://ir.pharmacyte.com/annual-reports?page=2#document-2838-0001683168-26-000147 <![CDATA[ 4 - Statement of changes in beneficial ownership of securities ]]> 4, EX-24.1 ]]> https://ir.pharmacyte.com/annual-reports?page=2#document-2840-0001683168-26-000148 Wed, 07 Jan 26 17:44:21 -0500 https://ir.pharmacyte.com/annual-reports?page=2#document-2840-0001683168-26-000148 <![CDATA[ 10-Q - Quarterly report [Sections 13 or 15(d)] ]]> 10-Q, EX-31.1, EX-31.2, EX-32.1, EX-32.2 ]]> https://ir.pharmacyte.com/annual-reports?page=2#document-2837-0001683168-25-009259 Thu, 18 Dec 25 17:05:02 -0500 https://ir.pharmacyte.com/annual-reports?page=2#document-2837-0001683168-25-009259